Keyphrases
Triple-negative Breast Cancer
100%
LY6K
60%
Tumor Progression
42%
Epigenetics
40%
Poor Prognosis
40%
Breast Cancer
34%
MicroRNA
25%
Breast Cancer Cells
23%
Cancer Progression
22%
Triple-negative Breast Cancer Cells
20%
Arrestin
20%
Checkpoint Kinase 1 (CHK1)
20%
MiR-320a
20%
Thymus
20%
MiRNA-181a
20%
Cold Shock Domain
20%
MAGEA12
20%
Oxaliplatin
20%
Transgenic Overexpression
20%
MiR-374a-5p
20%
T Cell Development
20%
Breast Carcinoma
20%
Autophagy
20%
Cell Mobility
20%
Hypomethylation
20%
Rac1
20%
Estrogen Receptor 1 (ESR1)
20%
ATP1A1
20%
Cell Aggressiveness
20%
Cell Cycle Arrest
20%
S-adenosylhomocysteine Hydrolase
20%
Mage
20%
ATG5
20%
Autophagy Pathway
20%
Metastasis Prognosis
20%
Cell Proliferation
20%
Cell-to-cell
20%
Cancer Stemness
20%
Estrogen Receptor
20%
Overexpression
16%
Breast Cancer Patients
14%
MCF-7
12%
Breast Cancer Subtypes
12%
Transgenic Mice
11%
Tamoxifen Resistance
9%
Therapeutic Target
9%
Cancer Stem Cells
8%
Autophagic Flux
8%
RNA Polymerase II (RNAPII)
8%
Cancer Cell Growth
7%
Biochemistry, Genetics and Molecular Biology
MicroRNA
61%
Tumor Progression
43%
Cancer Cell
41%
Kinase
22%
Phosphotransferase
22%
Autophagy
20%
Cell Proliferation
20%
Cell Motility
20%
RAC1
20%
Arrestin Beta 1
20%
Hydrolase
20%
Drive
20%
CpG Island
20%
Cell Cycle Arrest
20%
Estrogen Receptor Alpha
20%
DNA Methylation
20%
Epigenetics
20%
Estrogen Receptor
20%
S-Adenosyl-L-Homocysteine
20%
Cell Cycle Checkpoint
20%
RNA Polymerase II
15%
C-Terminus
15%
Cell Growth
13%
Transcription
12%
Gene Expression
10%
P53
8%
Methylation
8%
Cell Migration
8%
Downregulation
7%
DNA Damage Response
6%
Overall Survival
6%
Binding Domain
5%
ATPase
5%
Cell Invasion
5%
Alpha Chain
5%
Messenger RNA
5%
Medicine and Dentistry
Breast Cancer
60%
Triple Negative Breast Cancer
40%
Cancer Cell
32%
Metastatic Carcinoma
29%
Tamoxifen
24%
Upregulation
24%
microRNA
23%
Tumor Progression
23%
Estrogen Receptor Alpha
20%
T Cell Development
20%
Oxaliplatin
20%
Beta Arrestin 1
20%
Transgenic Mouse
20%
Checkpoint Kinase 1
20%
Estrogen Receptor
20%
Thymus
20%
CpG Island
20%
Breast Carcinoma
20%
Malignant Neoplasm
16%
T Cell
12%
Melanoma Antigen
10%
Lymphocyte Antigen
8%
Methylation
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Cancer Growth
6%
RNA Sequencing
6%
DNA Damage Response
6%
Hormone Receptor
6%
Histone Modification
6%
Overall Survival
6%
Distant Metastasis
5%
microRNA 192
5%
Cell Migration
5%
In Vitro
5%
